XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > NASDAQ and required Rollback

<< Previous

Bullboard Posts

Next >>

Comment by Richmondon Aug 15, 2021 12:56pm

82 Views

Post# 33707423

RE:RE:NASDAQ and required Rollback

You must be a Management Guy who doesn't like Shareholders/ Investors plight on ROLLBACK 45:1 or 5:1 or even 2:1....Just not a GOOD BUSINESS PRACTICE!!!!. ROLLBACKS ARE BIG TIME FAILURES!!.....JUST RELEASE SOME VALUE FILLED NRs znd Share Price will fly....STOP ROLLBACK. REPORT TO SEC!!!!

13X2413 wrote:
Thanks for providing some positive input. Hope you're right.

Something just didn't seem right, I may have been a bit too panicky

Signed,
Previous Garbage Poster.